Golden Sunrise Nutraceutical, Inc.

Last Updated:
Case Status:
Pending
Federal Trade Commission, Plaintiff, v. Golden Sunrise Nutraceutical, Inc., a corporation; Golden Sunrise Pharmaceutical, Inc., a corporation; Huu Tieu, individually and as an officer of Golden Sunrise Nutraceutical, Inc. and Golden Sunrise Pharmaceutical, Inc.; and Stephen Meis, individually and as an officer of Golden Sunrise Nutraceutical, Inc.; Defendants.
FTC Matter/File Number:

202 3146

Civil Action Number:

1:20-at-00540

Enforcement Type:

Federal Injunctions

Federal Court:
Eastern District of California

Case Summary

In July 2020, the Federal Trade Commission filed a complaint in federal court against the California-based marketers and promoters of bogus treatments for serious medical conditions.  The defendants are two corporations headquartered in Porterville, California, and two of their executives: Huu Tieu, President and CEO of both companies; and Stephen Weis, Medical Director and board member of Golden Sunrise Nutraceutical.  The complaint alleges that defendants have promoted and sold a variety of products through "plans of care" ranging in price from $23,000 to $200,000, which falsely claim to treat or cure COVID-19, cancer, Parkinson's disease, etc.